What Happened?
, -based Sage Therapeutics Appointed Lee Guidetti as Vice President Talent Acquisition
Date of management change: April 11, 2022
, -based Sage Therapeutics Appointed Lee Guidetti as Vice President Talent Acquisition
Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders. Sage`s lead product candidate, ZULRESSO(TM) (brexanolone) injection, has completed Phase 3 clinical development for postpartum depression and a New Drug Application is currently under review with the U.S. Food and Drug Administration. Sage is developing a portfolio of novel product candidates targeting critical CNS receptor systems, including SAGE-217, which is in Phase 3 development in major depressive disorder and postpartum depression.
Lee Guidetti is Vice President Talent Acquisition at Sage Therapeutics. Previously, Lee held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Bollermann Laura, Lee Matty, Jimenez Jenaro, Bradley Monica, Givogue Yvan Richard, Koronaios John, Hulbert Edward, Mullen Amanda, Farid Michael, Lin Dechun, Rajala Jonathan
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.